开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2023-11-06 侠胆医心来自威斯康星

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：睡眠;失眠;睡眠医学
经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知：

Guide for authors
Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief
Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals.

如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了

67 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2021-12-11 科研小白冬

请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。

166 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2023-03-01 ms6000000468947111 来自四川省

The

71 0

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2022-06-13 76236667

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：OSA
经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不

149 0

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

researcharticle一般写作顺序是什么？

159 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2021-12-29 MS54455111222

为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？

149 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2017-07-16 13305510181

涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了

400 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2014-11-30 匿名用户

审稿速度:2.0
经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。

433 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2019-06-02 whoever me

你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span

293 0

[GetPortalCommentsPageByObjectIdResponse(id=2166924, encodeId=effd2166924af, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：睡眠;失眠;睡眠医学 经验分享：这是专门发表综述的期刊，因此，只接受约稿。一般编辑部会请全球这个领域的牛人写长篇文章，每一期发表3-6篇文章。看看下面的作者需知： Guide for authors Sleep Medicine Reviews commissions all its articles. Should you be interested in writing for the journal, please contact the Editors-in-Chief Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. 如果你有好的综述，可以先联系主编，问一下能不能投这样的综述，如果对方同意，他们就会向你发约稿，你就可以投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Mon Nov 06 00:47:36 CST 2023, time=2023-11-06, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=1079154, encodeId=1d8c10e91546d, content=请问哪个大佬有这个杂志的格式要求啊，我看官网都没有任何描述的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05315469050, createdName=科研小白冬, createdTime=Sat Dec 11 23:20:25 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116997, encodeId=1cfe211699ebf, content=The , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb98563351, createdName=ms6000000468947111, createdTime=Wed Mar 01 09:02:23 CST 2023, time=2023-03-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1226197, encodeId=b385122619e61, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：OSA 经验分享：这个杂志在睡眠领域还是很厉害的，喜欢meta和综述，就是不知道他接收论著不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a62776476, createdName=76236667, createdTime=Mon Jun 13 17:05:30 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098191, encodeId=10b110981919e, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098192, encodeId=5f221098192f6, content=为什么建议从结果开始撰写researcharticle？从方法部分开始撰写可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544371, encodeId=69215443e11b, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=400, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508030, encodeId=05e3508030f7, content=审稿速度:2.0 经验分享：刚发掉一篇，相对于文章数目来说，审稿速度偏慢，审稿人意见非常nice，诸多溢美之词。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 18:46:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571801, encodeId=2e1f5e18013d, content=你好想请问一下这个杂志一般是需要约稿的吗没有约稿自己可以投的吗spanclassquote133018120170716发表brSCI20148513SCI20157341SCI20168958涨就一个字喜迎上涨看这个势头未来突破10分在望我在安徽能发一篇满意了span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af342055066, createdName=whoever me, createdTime=Sun Jun 02 10:35:00 CST 2019, time=2019-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571430, encodeId=23c25e143032, content=必须全是综述吗lisongsw 2011-06-28 15:55:00 发表: , beContent=lisongsw 2011-06-28 15:55:00 发表: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/24/ba475390faf056451fccb30bff373956.jpg, createdBy=c39a5107736, createdName=潞州郡王, createdTime=Fri May 24 00:00:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]

2019-05-24 潞州郡王

必须全是综述吗lisongsw 2011-06-28 15:55:00 发表:

lisongsw 2011-06-28 15:55:00 发表:

271 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务